Link to this page
National Drug File - Reference Terminology
Last uploaded:
July 6, 2018
Jump to:
| Preferred Name | Cytarabine [Chemical/Ingredient] | |
| Synonyms |
Arabinosylcytosine Aracytidine 2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl- Cytosine Arabinoside Arabinofuranosylcytosine Cytarabine |
|
| ID |
http://purl.bioontology.org/ontology/NDFRT/N0000006080 |
|
| altLabel |
Arabinosylcytosine Aracytidine 2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl- Cytosine Arabinoside Arabinofuranosylcytosine Cytarabine
|
|
| cui |
C0010711
|
|
| Ingredient of |
http://purl.bioontology.org/ontology/NDFRT/N0000023483 http://purl.bioontology.org/ontology/NDFRT/N0000151581 http://purl.bioontology.org/ontology/NDFRT/N0000192047 http://purl.bioontology.org/ontology/NDFRT/N0000190618 |
|
| MESH DEFINITION |
A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)
|
|
| MESH DUI |
D003561
|
|
| MeSH name |
Cytarabine
|
|
| MESH UI |
M0005564
|
|
| NDFRT kind |
INGREDIENT_KIND
|
|
| notation |
N0000006080
|
|
| NUI |
N0000006080
|
|
| prefLabel |
Cytarabine [Chemical/Ingredient]
|
|
| tui |
T114 T121
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping